A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.

NCT00448591 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2296

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: bevacizumab [Avastin]
DRUG: Taxane-based chemotherapy

Sponsor

Hoffmann-La Roche